Mary Lareine Pastoral, MD
Internal Medicine · Westerville
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 5
- Since medical school
- 15 years
- Graduated 2011
Offices
5 locations · Central Ohio Primary Care Physicians, Inc. · 487 clinicians in this group
Hospitals listed: Grant Medical Center · Ohio State University Hospitals · Riverside Methodist Hospital. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Pastoral’s office to ask if they take your plan before you enroll.
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Grant Medical CenterColumbus, OHAcute Care Hospital · Voluntary non-profit - Church · Has an emergency department · Birthing-friendlyPart of Ohiohealth, which runs 14 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — Pressure ulcer rate: 1.33 (0.76 to 1.9) · 5,250 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.194, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.686, Oct 2024 – Sep 2025
- Ohio State University State Health SystemColumbus, OHAcute Care Hospital · Government - State · Has an emergency department · Birthing-friendlyPart of The Ohio State University Wexner Medical Center, which runs 8 hospitalsHome of Ohio State University Comprehensive Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 3 of 5 · 74% would definitely recommend itOverall rating: 3 of 5 starsWorse than the national rate — SSI - Abdominal Hysterectomy: 3.329, Oct 2024 – Sep 2025Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.6, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.498, Oct 2024 – Sep 2025
- Riverside Methodist HospitalColumbus, OHAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Ohiohealth, which runs 14 hospitalsPatients rate it 3 of 5 · 76% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.222, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.801, Oct 2024 – Sep 2025
See every measure and the patient survey for Grant Medical Center
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 1 better, 8 the same, 2 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Pressure ulcer rateComplications and deaths | 1.33 (0.76 to 1.9) · 5,250 cases | Worse | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.194 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.686 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.98 (0.05 to 1.92) · 1,282 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.13 (0.85 to 1.41) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 202.44 (161.35 to 243.53) · 133 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.9 · 37 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.8 · 61 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 13.1 · 129 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.7 · 284 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.3 · 307 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.8 · 252 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 4,793 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.15 (0 to 0.35) · 5,833 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.05 to 0.44) · 5,708 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.79 (1 to 4.58) · 2,068 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 3.13 (1.6 to 4.65) · 823 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.68 (0.3 to 3.05) · 1,896 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.26 (0.32 to 12.19) · 724 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.58 (2.17 to 9) · 805 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.52 (0.1 to 2.95) · 382 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.2 · 144 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 1.021 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.397 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 1.036 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.963 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.2 · 257 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.9 · 787 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 16.7 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 21.2 · 356 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 25.9 · 348 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.1 · 912 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.3 (3.7 to 7.8) · 217 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.1 (10 to 17.2) · 217 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.3 · 162 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.5 · 61 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 282 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.4 (9.9 to 18) · 187 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.3) · 815 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,065 patients answered, 22% of those asked)
| Cleanliness | 3 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 3 |
| Room was "always" clean | 69% |
| Nurses "always" communicated well | 74% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 72% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 68% |
| Staff "always" explained new medications | 69% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 57% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
See every measure and the patient survey for Ohio State University State Health System
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 11 the same, 0 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Abdominal HysterectomyInfections | 3.329 | Worse | Oct 2024 – Sep 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.6 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.498 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.99 (0.21 to 1.77) · 3,100 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.96 (0.77 to 1.14) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 192.6 (163.31 to 221.9) · 349 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.3 · 144 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.9 · 134 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.8 · 159 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.5 · 695 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 11.2 · 354 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12.9 · 942 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 6,180 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.14 (0 to 0.3) · 14,138 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.29 (0.13 to 0.46) · 14,833 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.43 (2.01 to 4.85) · 4,450 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.57 (1.54 to 3.61) · 2,026 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.2 (1.05 to 3.35) · 3,639 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.88 (6.37 to 13.39) · 2,231 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.82 (3.5 to 8.14) · 2,130 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.39 (1.13 to 3.66) · 1,065 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.28 (0 to 0.65) · 12,527 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.9 · 120 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.867 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.093 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.129 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.5 · 302 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.4 · 1,369 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -24.4 · 199 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -5.6 · 862 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -9.2 · 398 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 14.7 · 661 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (3.3 to 7.9) · 54 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 8.7 (6 to 12.5) · 54 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.7 · 116 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 13.5 · 157 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.1 · 361 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 15.8 (12.4 to 20.2) · 1,554 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,241 cases | No different | Jan 2024 – Dec 2024 |
What patients said (2,595 patients answered, 21% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 65% |
| Nurses "always" communicated well | 78% |
| Doctors "always" communicated well | 78% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 74% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 55% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
See every measure and the patient survey for Riverside Methodist Hospital
Behind the star rating — Deaths: 1 better, 7 the same, 0 worse of 8 measures. Safety: 4 better, 4 the same, 0 worse of 8 measures. Readmissions: 3 better, 8 the same, 0 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.222 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.801 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.73 (0.06 to 1.4) · 4,802 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.11 (0.92 to 1.3) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 165.19 (133.6 to 196.78) · 324 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.8 · 308 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 9 · 106 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.9 · 376 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10 · 876 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.4 · 539 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.4 · 1,209 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 8,962 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.17 (0.02 to 0.32) · 17,131 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.24 (0.08 to 0.4) · 17,668 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.79 (2.56 to 5.02) · 6,343 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.63 (0.46 to 2.79) · 2,520 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.08 (1.06 to 3.1) · 5,790 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.93 (6.36 to 13.5) · 2,553 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.77 (4.28 to 9.25) · 2,513 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.49 (0.2 to 2.77) · 1,498 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.84 (0.47 to 1.21) · 15,005 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.8 · 232 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.819 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.864 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.557 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.159 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.5 · 815 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 1,613 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 588 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -23.6 · 1,055 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -24.9 · 558 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.3 · 888 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.8 (3.1 to 7.5) · 64 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.1 (6.9 to 14.4) · 64 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.8 · 254 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 7.7 · 361 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19 · 223 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (9.7 to 16.9) · 594 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.1) · 1,083 cases | No different | Jan 2024 – Dec 2024 |
What patients said (520 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 78% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 84% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 71% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 74% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 58% |
| "YES", patients would definitely recommend the hospital | 76% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
Original Medicare doctor bills
$50,544
Medicare paid this office $50,544 for 152 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 89 | $14,491 | $90 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 56 | $6,726 | $120 |
| Influenza vaccine split virus, preservative free | 36 | $2,946 | $82 |
| Long return visit (40+ min) | 17 | $2,445 | $136 |
| New patient visit (45+ min) | 17 | $2,106 | $124 |
See all 18 services
| Return visit (30+ min) | 89 | $14,491 | $90 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 56 | $6,726 | $120 |
| Influenza vaccine split virus, preservative free | 36 | $2,946 | $82 |
| Long return visit (40+ min) | 17 | $2,445 | $136 |
| New patient visit (45+ min) | 17 | $2,106 | $124 |
| Short return visit (20+ min) | 33 | $2,056 | $54 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 73 | $1,460 | $12 |
| Administration of influenza virus vaccine | 36 | $1,094 | $30 |
| Insertion of needle into vein for collection of blood sample | 89 | $1,047 | $9 |
| Vitamin d-3 level | 32 | $986 | $29 |
| Blood test, lipids (cholesterol and triglycerides) | 59 | $853 | $13 |
| Blood test, thyroid stimulating hormone (tsh) | 35 | $724 | $16 |
| Hemoglobin a1c level | 57 | $581 | $10 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 62 | $495 | $8 |
| Blood test, comprehensive group of blood chemicals | 40 | $435 | $10 |
| Blood test, basic group of blood chemicals (calcium, total) | 36 | $365 | $8 |
| Liver function blood test panel | 28 | $232 | $8 |
| Cyanocobalamin (vitamin b-12) level | 15 | $222 | $15 |
Procedures Medicare counted
| Removal of tissue | 1-10 | None |
Who their Medicare patients are
152 Original Medicare patients in 2024. Average age 74 · Women 72% · Health risk score 1.00. At or below the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 66% · Depression 30% · Diabetes 24% · Chronic kidney disease 22% · Coronary heart disease 19% · Cancer 18% · COPD 15% · Atrial fibrillation 15%.
The office billed $102,777, Medicare allowed $59,626 and paid $50,544; for 1,362 services of 97 kinds; $5,595 of it was for drugs given in the office and $44,948 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 152 | 1,362 | 74 | 1.00 | $102,777 | $50,544 |
| 2023 | 80 | 287 | 72 | 1.34 | $62,001 | $15,357 |
| 2022 | 90 | 298 | 70 | 1.34 | $70,017 | $19,856 |
| 2021 | 27 | 69 | 64 | 1.17 | $12,433 | $4,935 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 5 services
| Return visit (30+ min) | 63 | $9,378 | $56 |
| Short return visit (20+ min) | 20 | $1,376 | $51 |
| Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | 12 | $910 | $76 |
| Long return visit (40+ min) | 11 | $558 | $46 |
| Administration of influenza virus vaccine | 13 | $344 | $26 |
2022: 3 services
| Return visit (30+ min) | 63 | $7,199 | $59 |
| Long return visit (40+ min) | 31 | $3,797 | $84 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 14 | $1,326 | $95 |
Medicaid work
$29,711 in 2023
Medicaid paid $29,711 for 762 billed services this clinician did in 2023, up to 43 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 508 | $27,450 |
| Short return visit (20+ min) | 41 | $1,642 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 31 | $619 |
| Medication list documented in medical record (COA) | 33 | $0 |
| Review of all medications by a prescribing practitioner or clinical pharmacist (such as, prescriptions, OTCs, herbal therapies and supplements) documented in the medical record (COA) | 20 | $0 |
| Most recent hemoglobin A1c (HbA1c) level less than 7.0% (DM) | 23 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 61 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 45 | $0 |
| 2023 | 762 | 8 | 43 | $29,711 |
| 2022 | 1,947 | 16 | 61 | $28,276 |
| 2021 | 967 | 17 | 47 | $9,121 |
See the largest Medicaid services in earlier years
2022
| Return visit (30+ min) | 355 | $18,503 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 146 | $4,039 |
| New patient visit (45+ min) | 25 | $2,024 |
| COMPREHENSIVE METABOLIC PANEL | 39 | $936 |
| 1ST HOSP IP/OBS HIGH 75 | 15 | $891 |
| COLLECTION VENOUS BLOOD VENIPUNCTURE | 239 | $698 |
| Thyroid stimulating hormone (TSH) | 29 | $684 |
| HEPATITIS C ANTIBODY | 13 | $416 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 20 | $84 |
| TOBACCO NON-USER | 223 | $0 |
| COLORECTAL CANCER SCREENING RESULTS DOC&REV | 52 | $0 |
| Patient screened for tobacco use and received tobacco cessation intervention (counseling, pharmacotherapy, or both), if identified as a tobacco user (PV, CAD) | 71 | $0 |
2021
| New patient visit (45+ min) | 40 | $3,166 |
| Return visit (30+ min) | 70 | $3,072 |
| Short return visit (20+ min) | 30 | $1,060 |
| Thyroid stimulating hormone (TSH) | 14 | $417 |
| Measurement of vitamin D 25 hydroxy | 12 | $331 |
| HEPATITIS C ANTIBODY | 15 | $306 |
| COMPREHENSIVE METABOLIC PANEL | 14 | $288 |
| Infectious agent antigen detection by immunoassay technique (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], fluorescence immunoassay [FIA], immunochemiluminometric assay [IMCA]), qualitative or semiquantitative; HIV-1 antigen(s), with HIV-1 and HIV-2 antibodies, single result | 14 | $254 |
| COLLECTION VENOUS BLOOD VENIPUNCTURE | 86 | $227 |
| TOBACCO NON-USER | 146 | $0 |
| COLORECTAL CANCER SCREENING RESULTS DOC&REV | 31 | $0 |
| Patient screened for tobacco use and received tobacco cessation intervention (counseling, pharmacotherapy, or both), if identified as a tobacco user (PV, CAD) | 19 | $0 |
Drugs they prescribed that Part D paid
$182,277
Pharmacies billed $182,277 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 1% of their Part D prescriptions (20 of 2,078) in 2024. At or below the middle of the specialty; the typical internal medicine clinician is at 1%.
1,796 generic and 266 brand-name prescriptions · $182,277 in drug cost · 37 antibiotic prescriptions to 25 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ozempic | 33 | $32,473 | $984 |
| Jardiance | 20 | $20,125 | $1,006 |
| Eliquis | 15 | $18,052 | $1,203 |
| Januvia | 18 | $15,993 | $889 |
| Atorvastatin | 169 | $1,564 | $9 |
See all 49 drugs
| Ozempic | 33 | $32,473 | $984 |
| Jardiance | 20 | $20,125 | $1,006 |
| Eliquis | 15 | $18,052 | $1,203 |
| Januvia | 18 | $15,993 | $889 |
| Atorvastatin | 169 | $1,564 | $9 |
| Duloxetine | 24 | $1,217 | $51 |
| Rosuvastatin | 78 | $1,069 | $14 |
| Levothyroxine | 94 | $782 | $8 |
| Pantoprazole | 54 | $718 | $13 |
| Losartan | 82 | $666 | $8 |
| Albuterol Sulfate Hfa | 23 | $640 | $28 |
| Amlodipine Besylate | 100 | $621 | $6 |
| Gabapentin | 30 | $528 | $18 |
| Omeprazole | 45 | $477 | $11 |
| Potassium Chloride | 19 | $469 | $25 |
| Metoprolol | 39 | $427 | $11 |
| Lisinopril | 71 | $412 | $6 |
| Bupropion Xl | 20 | $374 | $19 |
| Tamsulosin | 19 | $371 | $20 |
| Tizanidine | 12 | $321 | $27 |
| Buspirone | 21 | $254 | $12 |
| Nystatin | 11 | $250 | $23 |
| Lactulose | 14 | $233 | $17 |
| Escitalopram | 15 | $218 | $15 |
| Carvedilol | 25 | $216 | $9 |
| Metformin | 34 | $213 | $6 |
| Fluoxetine | 14 | $210 | $15 |
| Fluticasone Propionate | 13 | $207 | $16 |
| Allopurinol | 15 | $198 | $13 |
| Losartan-Hydrochlorothiazide | 27 | $184 | $7 |
| Venlafaxine Hcl Er | 14 | $166 | $12 |
| Sertraline | 24 | $160 | $7 |
| Hydrochlorothiazide | 24 | $159 | $7 |
| Oxybutynin Chloride Er | 11 | $158 | $14 |
| Metformin Hcl Er | 34 | $154 | $5 |
| Pregabalin | 11 | $149 | $14 |
| Simvastatin | 23 | $143 | $6 |
| Clopidogrel | 12 | $138 | $11 |
| Montelukast | 19 | $133 | $7 |
| Olmesartan Medoxomil | 11 | $127 | $12 |
| Sumatriptan | 14 | $112 | $8 |
| Metoprolol | 17 | $95 | $6 |
| Furosemide | 23 | $94 | $4 |
| Citalopram Hbr | 13 | $73 | $6 |
| Pravastatin | 15 | $67 | $4 |
| Meloxicam | 13 | $58 | $4 |
| Tramadol | 19 | $45 | $2 |
| Clonidine | 11 | $39 | $4 |
| Prednisone | 12 | $22 | $2 |
Year by year
| 2024 | 2,078 | 437 | 1% (20) | 13% | $182,277 |
| 2023 | 4,855 | 364 | 0% (18) | 12% | $402,470 |
| 2022 | 2,983 | 315 | 0% (12) | 10% | $211,415 |
| 2021 | 467 | 107 | None | 10% | $36,292 |
| 2020 | 349 | 57 | 0% (0) | 12% | $22,515 |
| 2019 | 449 | 66 | 2% (11) | None | $31,912 |
| 2018 | 197 | 41 | 0% (0) | None | $8,488 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 97 drugs
| Eliquis | 29 | $31,530 | $1,087 |
| Jardiance | 36 | $28,111 | $781 |
| Trulicity | 21 | $26,320 | $1,253 |
| Ozempic | 20 | $21,512 | $1,076 |
| Xarelto | 19 | $17,181 | $904 |
| Spiriva Handihaler | 15 | $15,795 | $1,053 |
| Symbicort | 21 | $11,028 | $525 |
| Lantus Solostar | 19 | $10,374 | $546 |
| Advair Hfa | 14 | $9,872 | $705 |
| Praluent | 13 | $6,804 | $523 |
| Anoro Ellipta | 11 | $5,390 | $490 |
| Insulin Aspart Flexpen | 17 | $5,195 | $306 |
| Atorvastatin | 342 | $4,587 | $13 |
| Levemir | 12 | $4,044 | $337 |
| Levothyroxine | 210 | $3,522 | $17 |
| Losartan | 220 | $3,104 | $14 |
| Duloxetine | 49 | $2,836 | $58 |
| Synthroid | 33 | $2,701 | $82 |
| Albuterol Sulfate Hfa | 63 | $2,428 | $39 |
| Pantoprazole | 156 | $2,328 | $15 |
| Omeprazole | 134 | $1,999 | $15 |
| Lisinopril | 247 | $1,910 | $8 |
| Metoprolol | 96 | $1,696 | $18 |
| Losartan-Hydrochlorothiazide | 53 | $1,456 | $27 |
| Amlodipine Besylate | 212 | $1,385 | $7 |
| Gabapentin | 74 | $1,181 | $16 |
| Solifenacin | 13 | $1,149 | $88 |
| Pravastatin | 75 | $1,135 | $15 |
| Bupropion Xl | 25 | $1,065 | $43 |
| Ventolin Hfa | 17 | $1,060 | $62 |
| Rosuvastatin | 70 | $1,005 | $14 |
| Diclofenac | 20 | $1,001 | $50 |
| Metformin | 98 | $982 | $10 |
| Chlorthalidone | 39 | $969 | $25 |
| Metformin Hcl Er | 58 | $896 | $15 |
| Oxybutynin Chloride Er | 22 | $795 | $36 |
| Montelukast | 57 | $786 | $14 |
| Levocetirizine Dihydrochloride | 44 | $785 | $18 |
| Simvastatin | 77 | $762 | $10 |
| Valsartan | 17 | $752 | $44 |
| Fluticasone Propionate | 44 | $744 | $17 |
| Hydroxyzine | 24 | $735 | $31 |
| Potassium Chloride | 28 | $712 | $25 |
| Tamsulosin | 31 | $703 | $23 |
| Nystatin | 21 | $700 | $33 |
| Ropinirole | 14 | $665 | $47 |
| Escitalopram | 32 | $637 | $20 |
| Tizanidine | 24 | $585 | $24 |
| Carvedilol | 52 | $577 | $11 |
| Sure Comfort Pen Needle | 11 | $565 | $51 |
| Famotidine | 23 | $553 | $24 |
| Lactulose | 28 | $498 | $18 |
| Ezetimibe | 19 | $481 | $25 |
| Metoprolol | 61 | $476 | $8 |
| Buspirone | 22 | $473 | $21 |
| Glimepiride | 33 | $448 | $14 |
| Furosemide | 66 | $419 | $6 |
| Amoxicillin-Clavulanate Potass | 34 | $368 | $11 |
| Pioglitazone | 13 | $363 | $28 |
| Fluoxetine | 38 | $361 | $9 |
| Lidocaine-Prilocaine | 13 | $355 | $27 |
| Doxycycline Hyclate | 22 | $354 | $16 |
| Sertraline | 37 | $344 | $9 |
| Hydrochlorothiazide | 84 | $333 | $4 |
| Venlafaxine Hcl Er | 12 | $313 | $26 |
| Citalopram Hbr | 34 | $302 | $9 |
| Trazodone | 27 | $289 | $11 |
| Dicyclomine | 12 | $286 | $24 |
| Clopidogrel | 15 | $284 | $19 |
| Alendronate | 22 | $248 | $11 |
| Diltiazem 24hr Er (Cd) | 12 | $245 | $20 |
| Oxybutynin Chloride | 11 | $231 | $21 |
| Donepezil | 16 | $231 | $14 |
| Ibuprofen | 13 | $221 | $17 |
| Warfarin | 19 | $214 | $11 |
| Allopurinol | 18 | $198 | $11 |
| Azithromycin | 36 | $196 | $5 |
| Spironolactone | 11 | $187 | $17 |
| Lisinopril-Hydrochlorothiazide | 31 | $182 | $6 |
| Prednisone | 42 | $175 | $4 |
| Nitrofurantoin Mono-Macro | 13 | $153 | $12 |
| Sumatriptan | 11 | $152 | $14 |
| Clonidine | 16 | $149 | $9 |
| Meclizine | 16 | $140 | $9 |
| Topiramate | 15 | $140 | $9 |
| Glipizide | 11 | $139 | $13 |
| Amitriptyline | 16 | $138 | $9 |
| Verapamil | 11 | $121 | $11 |
| Lorazepam | 17 | $119 | $7 |
| Fluconazole | 13 | $112 | $9 |
| Easy Touch Alcohol Prep Pads | 13 | $93 | $7 |
| Zolpidem | 20 | $73 | $4 |
| Meloxicam | 13 | $63 | $5 |
| Ciprofloxacin | 11 | $58 | $5 |
| Hydroxyzine Pamoate | 12 | $45 | $4 |
| Alprazolam | 20 | $37 | $2 |
| Triamcinolone Acetonide | 11 | $35 | $3 |
2022: 65 drugs
| Trulicity | 17 | $23,661 | $1,392 |
| Eliquis | 15 | $15,679 | $1,045 |
| Lantus Solostar | 18 | $10,066 | $559 |
| Symbicort | 14 | $7,193 | $514 |
| Vascepa | 12 | $6,967 | $581 |
| Advair Diskus | 11 | $5,193 | $472 |
| Levothyroxine | 142 | $2,931 | $21 |
| Albuterol Sulfate Hfa | 52 | $2,615 | $50 |
| Atorvastatin | 195 | $2,401 | $12 |
| Omeprazole | 95 | $1,492 | $16 |
| Rosuvastatin | 23 | $1,452 | $63 |
| Pantoprazole | 76 | $1,444 | $19 |
| Synthroid | 23 | $1,300 | $57 |
| Esomeprazole Magnesium | 12 | $1,254 | $104 |
| Duloxetine | 20 | $873 | $44 |
| Montelukast | 39 | $873 | $22 |
| Metoprolol | 58 | $866 | $15 |
| Gabapentin | 42 | $848 | $20 |
| Pravastatin | 67 | $835 | $12 |
| Amlodipine Besylate | 104 | $834 | $8 |
| Lisinopril | 134 | $774 | $6 |
| Nystatin | 33 | $754 | $23 |
| Losartan-Hydrochlorothiazide | 30 | $675 | $22 |
| Losartan | 79 | $637 | $8 |
| Lactulose | 25 | $537 | $21 |
| Hydroxyzine | 22 | $507 | $23 |
| Metformin | 77 | $505 | $7 |
| Fluoxetine | 21 | $500 | $24 |
| Chlorthalidone | 18 | $487 | $27 |
| Fluticasone Propionate | 27 | $468 | $17 |
| Valsartan | 11 | $468 | $43 |
| Potassium Chloride | 22 | $448 | $20 |
| Diltiazem 24hr Er (Cd) | 21 | $427 | $20 |
| Diclofenac | 17 | $422 | $25 |
| Metoprolol | 43 | $408 | $9 |
| Simvastatin | 62 | $383 | $6 |
| Metformin Hcl Er | 41 | $358 | $9 |
| Hydrochlorothiazide | 76 | $329 | $4 |
| Lisinopril-Hydrochlorothiazide | 34 | $326 | $10 |
| Venlafaxine Hcl Er | 15 | $310 | $21 |
| Oxybutynin Chloride Er | 16 | $302 | $19 |
| Allopurinol | 15 | $291 | $19 |
| Sertraline | 21 | $280 | $13 |
| Carvedilol | 32 | $277 | $9 |
| Topiramate | 14 | $264 | $19 |
| Escitalopram | 18 | $248 | $14 |
| Bupropion Xl | 12 | $233 | $19 |
| Nitrofurantoin Mono-Macro | 14 | $233 | $17 |
| Clopidogrel | 14 | $228 | $16 |
| Amoxicillin-Clavulanate Potass | 14 | $208 | $15 |
| Glimepiride | 18 | $197 | $11 |
| Famotidine | 12 | $184 | $15 |
| Citalopram Hbr | 30 | $184 | $6 |
| Levocetirizine Dihydrochloride | 11 | $174 | $16 |
| Amitriptyline | 18 | $165 | $9 |
| Atenolol | 13 | $162 | $12 |
| Tizanidine | 19 | $160 | $8 |
| Alendronate | 21 | $158 | $8 |
| Trazodone | 12 | $154 | $13 |
| Warfarin | 16 | $143 | $9 |
| Furosemide | 35 | $119 | $3 |
| Prednisone | 20 | $110 | $5 |
| Clonidine | 17 | $106 | $6 |
| Azithromycin | 16 | $105 | $7 |
| Lorazepam | 18 | $81 | $4 |
2021: 9 drugs
| Atorvastatin | 41 | $616 | $15 |
| Levothyroxine | 15 | $339 | $23 |
| Pantoprazole | 12 | $323 | $27 |
| Gabapentin | 14 | $259 | $18 |
| Amlodipine Besylate | 38 | $176 | $5 |
| Fluticasone Propionate | 11 | $157 | $14 |
| Lisinopril | 16 | $145 | $9 |
| Amoxicillin-Clavulanate Potass | 11 | $99 | $9 |
| Hydrochlorothiazide | 19 | $53 | $3 |
2020: 7 drugs
| Atorvastatin | 32 | $594 | $19 |
| Gabapentin | 13 | $386 | $30 |
| Levothyroxine | 12 | $383 | $32 |
| Pantoprazole | 13 | $168 | $13 |
| Amlodipine Besylate | 17 | $158 | $9 |
| Lisinopril | 13 | $122 | $9 |
| Hydrochlorothiazide | 13 | $49 | $4 |
2019: 10 drugs
| Atorvastatin | 46 | $764 | $17 |
| Fluticasone Propionate | 13 | $372 | $29 |
| Levothyroxine | 13 | $353 | $27 |
| Omeprazole | 17 | $273 | $16 |
| Gabapentin | 14 | $245 | $18 |
| Lisinopril | 28 | $139 | $5 |
| Amlodipine Besylate | 23 | $134 | $6 |
| Metoprolol | 12 | $97 | $8 |
| Hydrochlorothiazide | 23 | $89 | $4 |
| Metformin | 18 | $65 | $4 |
2018: 2 drugs
| Atorvastatin | 26 | $390 | $15 |
| Lisinopril | 13 | $46 | $4 |
Money from drug and device companies
$870 in 2025
| 2025 | 17 | 49 | None | $870 |
| 2024 | 17 | 74 | None | $1,262 |
| 2023 | 3 | 6 | None | $126 |
| 2022 | 3 | 4 | None | $74 |
| 2021 | 1 | 1 | None | $16 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| AstraZeneca Pharmaceuticals LP | Airsupra | $164 | 8 payments
|
| Abbvie | Qulipta | $143 | 8 payments
|
| Lilly USA | Jardiance | $96 | 5 payments
|
| GlaxoSmithKline | Trelegy Ellipta | $74 | 4 payments
|
| Amgen | Otezla | $68 | 4 payments
|
| Xeris Pharmaceuticals | Gvoke Hypopen | $43 | 2 payments
|
See all 45 published payments
| Abbvie | Meals · 2025-12-05 | Qulipta | $7 |
| Abbvie | Meals · 2025-11-26 | Ubrelvy | $23 |
| Axsome Therapeutics | Meals · 2025-11-15 | Symbravo | $29 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-11-04 | Breztri | $15 |
| Abbvie | Meals · 2025-10-29 | Ubrelvy | $11 |
| GlaxoSmithKline | Meals · 2025-10-24 | Trelegy Ellipta | $18 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-10-22 | Airsupra | $18 |
| Exact Sciences | Meals · 2025-10-15 | Cologuard Collection Kit | $15 |
| Amgen | Meals · 2025-10-08 | Repatha | $14 |
| Lilly USA | Meals · 2025-10-03 | Jardiance | $20 |
| Pfizer | Meals · 2025-10-01 | Nurtec Odt | $19 |
| Amgen | Meals · 2025-09-12 | Krystexxa | $18 |
| Radius Health | Meals · 2025-08-29 | Tymlos | $17 |
| GlaxoSmithKline | Meals · 2025-08-27 | Trelegy Ellipta | $19 |
| Dexcom | Meals · 2025-08-25 | Dexcom G6 Transmitter | $18 |
| Amgen | Meals · 2025-08-22 | Evenity | $17 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-08-20 | Airsupra | $14 |
| Kowa Pharmaceuticals America | Meals · 2025-08-15 | Zoryve | $17 |
| Collegium Pharmaceutical | Meals · 2025-08-12 | Jornay Pm | $20 |
| Sumitomo Pharma America | Meals · 2025-07-25 | Myfembree | $18 |
| GlaxoSmithKline | Meals · 2025-07-18 | Trelegy Ellipta | $19 |
| Lilly USA | Meals · 2025-07-11 | Mounjaro | $26 |
| Regeneron Healthcare Solutions | Meals · 2025-07-09 | Dupixent | $37 |
| Abbvie | Meals · 2025-06-25 | Qulipta | $19 |
| Exact Sciences | Meals · 2025-06-18 | Cologuard Collection Kit | $20 |
| Abbvie | Meals · 2025-06-10 | Ubrelvy | $15 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-06-04 | Airsupra | $14 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-05-22 | Breztri | $15 |
| Lilly USA | Meals · 2025-05-21 | Jardiance | $20 |
| Abbvie | Meals · 2025-05-16 | Qulipta | $27 |
| Xeris Pharmaceuticals | Meals · 2025-05-09 | Gvoke Hypopen | $23 |
| Amgen | Meals · 2025-05-07 | Otezla | $19 |
| Xeris Pharmaceuticals | Meals · 2025-04-18 | Gvoke Hypopen | $20 |
| Novo Nordisk | Meals · 2025-04-02 | Ozempic | $19 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-03-31 | Airsupra | $14 |
| Lilly USA | Meals · 2025-03-25 | Jardiance | $16 |
| Pfizer | Meals · 2025-03-19 | Prevnar 20 | $22 |
| Abbvie | Meals · 2025-03-17 | Qulipta | $25 |
| Lilly USA | Meals · 2025-03-14 | Mounjaro | $15 |
| Novo Nordisk | Meals · 2025-03-12 | Rybelsus | $14 |
| Abbvie | Meals · 2025-02-21 | Ubrelvy | $16 |
| GlaxoSmithKline | Meals · 2025-02-14 | Trelegy Ellipta | $18 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-02-07 | Farxiga | $56 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-01-24 | Airsupra | $19 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-01-15 | Jardiance | $17 |
See earlier years (2024, 2023, 2022, 2021)
2024: $1,262
| GlaxoSmithKline | Trelegy Ellipta | $154 | 10 payments
|
| Abbvie | Qulipta | $152 | 8 payments
|
| Lilly USA | Mounjaro | $139 | 8 payments
|
| AstraZeneca Pharmaceuticals LP | Airsupra | $135 | 5 payments
|
| Novo Nordisk | Ozempic | $115 | 7 payments
|
| Pfizer | Prevnar 20 | $99 | 5 payments
|
| Amgen | Evenity | $80 | 4 payments
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $69 | 3 payments
|
| Exact Sciences | Cologuard Collection Kit | $66 | 3 payments
|
| Merck Sharp & Dohme | Gardasil | $44 | 3 payments
|
| Dexcom | Dexcom G6 Transmitter | $43 | 2 payments
|
| Phathom Pharmaceuticals | Voquezna | $43 | 2 payments
|
| Actelion Pharmaceuticals US | Opsumit | $42 | 2 payments
|
| Axsome Therapeutics | Auvelity | $33 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $19 | 1 payment
|
| Abbott Laboratories | Freestyle Libre 3 | $16 | 1 payment
|
| Shield Therapeutics | Accrufer | $14 | 1 payment
|
2023: $126
| Abbvie | Ubrelvy | $46 | 2 payments
|
| Dexcom | Dexcom G6 Transmitter | $41 | 2 payments
|
| Exact Sciences | Cologuard Collection Kit | $39 | 2 payments
|
2022: $74
| Dexcom | Dexcom G6 Transmitter | $34 | 2 payments
|
| Biohaven Pharmaceutical Holding Company | Nurtec Odt | $25 | 1 payment
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $14 | 1 payment
|
2021: $16
| Merck Sharp & Dohme | Gardasil 9 | $16 | 1 payment
|
Professional record
- NPI
- 1285138487
- Licence
- OH 35.141488
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Internal medicine (207R00000X); Student in a training program (390200000X)
- Mailing address
- 400 Altair Pkwy Ste 3300, Westerville, OH, 43082
- NPI first listed
- 2018-03-21
- NPI last updated
- 2023-10-13
- NPI record certified
- 2023-10-13
This is when the NPI record was last certified, not a medical board exam.